Pimicotinib Shows Robust Antitumour Activity and Clinically Meaningful Improvements in Patients with Tenosynovial Giant Cell Tumour By Ogkologos - March 18, 2026 293 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the MANEUVER study Source RELATED ARTICLESMORE FROM AUTHOR Comprehensive Genomic Profiling with Subsequent Molecularly Guided Therapy Improves Outcomes Over Platinum-based Chemotherapy in Previously Untreated, Unfavourable CUP NCI and CRUK Take on Cancer’s Toughest Problems Tebentafusp Continues to Provide Long-Term OS Benefit in Previously Untreated Patients with Unresectable or Metastatic Uveal Melanoma MOST POPULAR Precision drug slows progression of advanced breast cancer September 21, 2021 Extended Adjuvant Treatment with Letrozole Results in Longer Survival in Postmenopausal... September 17, 2021 FDA Approves Sotorasib with Panitumumab for KRAS G12C-mutated Colorectal Cancer February 13, 2025 ctDNA-Guided Therapy with Pertuzumab plus Trastuzumab for HER2-Amplified mCRC November 23, 2021 Load more HOT NEWS Workout Wednesdays – Chest Exercises Part 2 Breast cancer mortality down 66% in 20 years 2021 ASCO Annual Meeting Research Round Up: Advances in Genitourinary Cancers Long-Term Survival in a Significant Proportion of Patients with a 1p/19q...
